01 7Xenazine
02 3Xenazine?
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 29
2019 Revenue in Millions : 38
Growth (%) : -24
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 22
2020 Revenue in Millions : 29
Growth (%) : -24
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 38
2018 Revenue in Millions : 52
Growth (%) : -27
Main Therapeutic Indication : Rare Disease
Currency : USD
2015 Revenue in Millions : 254
2014 Revenue in Millions : 330
Growth (%) : 30%
Main Therapeutic Indication : Rare Disease
Currency : USD
2014 Revenue in Millions : 19%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 178
2016 Revenue in Millions : 267
Growth (%) : -33
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 66
2017 Revenue in Millions : 157
Growth (%) : -58%
Main Therapeutic Indication : Rare Diseases
Currency : USD
2016 Revenue in Millions : 157
2015 Revenue in Millions : 223
Growth (%) : -30
Main Therapeutic Indication : Rare Diseases
Currency : USD
2017 Revenue in Millions : 113
2016 Revenue in Millions : 157
Growth (%) : -28
Main Therapeutic Indication : Rare Diseases
Currency : USD
2018 Revenue in Millions : 52
2017 Revenue in Millions : 122
Growth (%) : -57%
LOOKING FOR A SUPPLIER?